
Wu Cheng Winston Shen
Supervisory Patent Examiner (ID: 11158, Phone: (571)272-3157 , Office: P/1628 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632, 1628, 1682, 1621, 1634 |
| Total Applications | 377 |
| Issued Applications | 62 |
| Pending Applications | 83 |
| Abandoned Applications | 242 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19067561
[patent_doc_number] => 20240101987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => POLYPEPTIDE FUSIONS OR CONJUGATES FOR GENE EDITING
[patent_app_type] => utility
[patent_app_number] => 18/351747
[patent_app_country] => US
[patent_app_date] => 2023-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351747
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/351747 | POLYPEPTIDE FUSIONS OR CONJUGATES FOR GENE EDITING | Jul 12, 2023 | Pending |
Array
(
[id] => 19096288
[patent_doc_number] => 20240115515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => LIVER-SPECIFIC DRUG DELIVERY CARRIER COMPRISING NUCLEIC ACID NANOPARTICLE AND CHOLESTEROL AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/166782
[patent_app_country] => US
[patent_app_date] => 2023-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166782
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166782 | LIVER-SPECIFIC DRUG DELIVERY CARRIER COMPRISING NUCLEIC ACID NANOPARTICLE AND CHOLESTEROL AND USE THEREOF | Feb 8, 2023 | Pending |
Array
(
[id] => 18628570
[patent_doc_number] => 20230287441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => PROGRAMMABLE INSERTION APPROACHES VIA REVERSE TRANSCRIPTASE RECRUITMENT
[patent_app_type] => utility
[patent_app_number] => 18/067214
[patent_app_country] => US
[patent_app_date] => 2022-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18067214
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/067214 | PROGRAMMABLE INSERTION APPROACHES VIA REVERSE TRANSCRIPTASE RECRUITMENT | Dec 15, 2022 | Pending |
Array
(
[id] => 18359972
[patent_doc_number] => 20230141563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IGM RESPONSES
[patent_app_type] => utility
[patent_app_number] => 17/964534
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17964534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/964534 | METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IGM RESPONSES | Oct 11, 2022 | Abandoned |
Array
(
[id] => 18921534
[patent_doc_number] => 20240024538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => EPITHELIAL CELL TUBE FOR TRACHEAL TRANSPLANTATION
[patent_app_type] => utility
[patent_app_number] => 17/907837
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907837
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907837 | EPITHELIAL CELL TUBE FOR TRACHEAL TRANSPLANTATION | Jun 16, 2022 | Pending |
Array
(
[id] => 17836379
[patent_doc_number] => 20220273684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => Systems and Methods to Identify Pancreatic Ductal Adenocarcinoma and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/653114
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653114
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653114 | Systems and Methods to Identify Pancreatic Ductal Adenocarcinoma and Uses Thereof | Feb 28, 2022 | Pending |
Array
(
[id] => 19156198
[patent_doc_number] => 20240148905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/277858
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -55
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277858
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277858 | METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS | Feb 17, 2022 | Pending |
Array
(
[id] => 19049411
[patent_doc_number] => 20240091380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES
[patent_app_type] => utility
[patent_app_number] => 18/274499
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274499
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274499 | GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES | Jan 30, 2022 | Pending |
Array
(
[id] => 19098123
[patent_doc_number] => 20240117351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/274826
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274826
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274826 | COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM | Jan 27, 2022 | Pending |
Array
(
[id] => 18862317
[patent_doc_number] => 20230416753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => SIRNA FOR TREATING HEPATIC FIBROSIS AND DELIVERY PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/037598
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037598
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/037598 | SIRNA FOR TREATING HEPATIC FIBROSIS AND DELIVERY PREPARATION THEREOF | Nov 18, 2021 | Pending |
Array
(
[id] => 18903008
[patent_doc_number] => 20240018493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/251941
[patent_app_country] => US
[patent_app_date] => 2021-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -100
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251941
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251941 | KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION | Nov 9, 2021 | Pending |
Array
(
[id] => 20193838
[patent_doc_number] => 20250270548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING TARDBP ASSOCIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/039928
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039928
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039928 | COMPOSITIONS AND METHODS FOR TREATING TARDBP ASSOCIATED DISEASES | Nov 7, 2021 | Pending |
Array
(
[id] => 18895539
[patent_doc_number] => 20240011024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => CRISPR SPACER TAGS FOR LABELING AND/OR IDENTIFYING BACTERIA, AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/251636
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13716
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251636
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251636 | CRISPR SPACER TAGS FOR LABELING AND/OR IDENTIFYING BACTERIA, AND METHODS OF USING THE SAME | Nov 3, 2021 | Pending |
Array
(
[id] => 18842636
[patent_doc_number] => 20230405040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITH LPA-TARGETED RNAi CONSTRUCTS
[patent_app_type] => utility
[patent_app_number] => 18/035198
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -144
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035198
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035198 | METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITH LPA-TARGETED RNAi CONSTRUCTS | Nov 3, 2021 | Pending |
Array
(
[id] => 18282936
[patent_doc_number] => 20230098408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => SINGLE NUCLEIC ACID FOR REAL-TIME DETECTION FOR SNP ANALYSIS OF APOE GENE AND DETECTION METHOD USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/449140
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17449140
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/449140 | SINGLE NUCLEIC ACID FOR REAL-TIME DETECTION FOR SNP ANALYSIS OF APOE GENE AND DETECTION METHOD USING THE SAME | Sep 27, 2021 | Abandoned |
Array
(
[id] => 17444199
[patent_doc_number] => 20220064704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS OF PREPARING LARGE QUANTITIES OF SINGLE-STRANDED DNA (ssDNA)
[patent_app_type] => utility
[patent_app_number] => 17/410925
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410925
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/410925 | METHODS OF PREPARING LARGE QUANTITIES OF SINGLE-STRANDED DNA (ssDNA) | Aug 23, 2021 | Abandoned |
Array
(
[id] => 17370385
[patent_doc_number] => 20220025437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => NOVEL METHOD OF COMBINED MOLECULAR CLAMPING AND ALLELE SPECIFIC qPCR TECHNOLOGY FOR KRAS G12C MUTATION DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/386451
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386451
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/386451 | NOVEL METHOD OF COMBINED MOLECULAR CLAMPING AND ALLELE SPECIFIC qPCR TECHNOLOGY FOR KRAS G12C MUTATION DETECTION | Jul 26, 2021 | Abandoned |
Array
(
[id] => 18565730
[patent_doc_number] => 20230256057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => TREATMENT OF IMMUNE DEPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/015820
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015820
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015820 | TREATMENT OF IMMUNE DEPRESSION | Jul 12, 2021 | Pending |
Array
(
[id] => 18537810
[patent_doc_number] => 20230242911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => MicroRNA-TARGETED THERAPY FOR CARDIAC REPAIR
[patent_app_type] => utility
[patent_app_number] => 18/004877
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004877
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004877 | MicroRNA-TARGETED THERAPY FOR CARDIAC REPAIR | Jul 8, 2021 | Pending |
Array
(
[id] => 19641419
[patent_doc_number] => 20240415939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/002767
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002767
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002767 | COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF | Jun 29, 2021 | Pending |